Federal contract award
75N95023F00001
REGULATORY SUPPORT FOR BITOX, A DETOXIFIED FORM OF BOTULISM NEUROTOXIN (BONT), AS A TREATMENT FOR CHRONIC NEUROPATHIC PAINS FOCUSING ON OSTEOARTHRITIS, A DEGENERATIVE JOINT DISEASE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75N95022D00014 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $79.3K |
| Current contract value | $79.3K |
| Potential contract value / ceiling | $654.2K |
| Start date | Sep 22, 2023 |
| Current end date | Mar 21, 2026 |
| Potential end date | Sep 21, 2026 |
| Latest award activity | Aug 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 29, 2025 | P00002 | $0 | REGULATORY SUPPORT FOR BITOX, A DETOXIFIED FORM OF BOTULISM NEUROTOXIN (BONT), AS A TREATMENT FOR CHRONIC NEUROPATHIC PAINS FOCUSING ON OSTEOARTHRITIS, A DEGENERATIVE JOINT DISEASE. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.